Biopharmaceutical Development Service by LGC

Manufacturer LGC  |  Available Worldwide
  |  1 reviews
LGC has established itself as a world-class leader in biopharmaceutical drug development through analytical excellence with over 200 scientists across three UK facilities.

Biopharmaceutical Development Service by LGC product image
Biopharmaceutical Development Service
Request Pricing

Receive your quote directly from the manufacturer.

Average Rating: 5.0
1 Scientist has reviewed this product

5 out of 5
Ease of use
5 out of 5
After sales service
5 out of 5
Value for money

  • Status:

  • Member since: 2016

  • Organization: ICON plc on behalf of VHsquared

  • Ease of use
    5 out of 5
    After sales service
    5 out of 5
    Value for money
    5 out of 5
Share this Review on LinkedinShare this Review on TwitterShare this Review on Facebook
Rating: 5.0

  • Application Area: PK and IG analysis in human matrices

"Quality, communication, punctuality and flexibility were all excellent."

Review date: 18 Nov 2016 | Biopharmaceutical Development Service

Our capabilities and experience cover recombinant proteins, vaccines, blood products, monoclonal antibodies, oligonucleotides, gene therapy products and more.

Development and validation of bioanalytical assays to support your biopharmaceutical development programme, whether it be Pharmacokinetic (PK), Anti-Drug-Antibody (ADA), Neutralising Antibodies (nAbs) or Pharmacodynamic (PD) is core to our business.

Our bioanalytical services for biopharmaceuticals include:

  • New method development
  • Method validation (GLP, GCP or non-regulated)
  • Sample analysis to support discovery, preclinical and clinical programmes
  • Macromolecule quantification and characterisation to support biopharmaceutical development and manufacture.

Experienced, qualified staff and investment in the latest technologies allow us to provide high quality bioanalytical services for biopharmaceuticals in support of all stages of your development.